Lumos Pharma
Austin
About Lumos Pharma
Lumos Pharma, based in Austin, Texas, is an early-stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency. Lumos Pharma is the exclusive licensee of technology and discoveries made in laboratories at the University of Cincinnati and has partnered with Key Opinion Leaders in the field and the United States National Institutes of Health to ensure success in developing a treatment for Creatine Transporter Deficiency. It was founded in 2014 and is headquartered in Austin, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $53.5M
- Funding stage: M&A
- Last round: Series B (Apr 2016)
- Ticker: nasdaq:LUMO
- Website: lumos-pharma.com
- Phone: 512-215-2630
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lumos-pharma-117375 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.